国立研究開発法人国立がん研究センターは、日本の国立研究開発法人。国立高度専門医療研究センターの一つであり、日本におけるがん征圧の中核拠点として、がんその他の悪性新生物に対する診療、研究、技術開発、治験、調査、政策提言、人材育成、情報提供を行う。

During the past decade, National Cancer Center Hospital; Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Center Hospital; Hematology" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Center Hospital; Hematology" are "Diffuse Large B-Cell Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "National Cancer Center Hospital; Hematology" in a lesser frequency.

Most popular intervention types in "National Cancer Center Hospital; Hematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials), "Prednisone" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Center Hospital; Hematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Cancer Center Hospital; Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in National Cancer Center Hospital; Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Center Hospital; Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".